COGT (STOCKS)
Cogent Biosciences, Inc. Common Stock
$36.520000
+0.150000 (+0.41%)
Prev close: $36.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Andrew R. Robbins
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,926.90M
- Employees
- 205
- P/E (TTM)
- -14.28
- P/B (TTM)
- 10.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $333.36M |
| Nonoperating Income/Loss | $4.43M |
| Depreciation and Amortization | $2.60M |
| Research and Development | $269.78M |
| Operating Income/Loss | -$333.36M |
| Income/Loss From Continuing Operations After Tax | -$328.94M |
| Income/Loss From Continuing Operations Before Tax | -$328.94M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$328.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$328.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$328.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.16 |
| Diluted Earnings Per Share | -$2.16 |
| Basic Average Shares | 128,899,408 |
| Diluted Average Shares | 128,899,408 |
| Assets | $937.61M |
| Current Assets | $910.36M |
| Noncurrent Assets | $27.25M |
| Fixed Assets | $5.46M |
| Other Non-current Assets | $21.80M |
| Liabilities | $301.24M |
| Current Liabilities | $63.95M |
| Accounts Payable | $9.50M |
| Wages | $15.74M |
| Other Current Liabilities | $38.71M |
| Noncurrent Liabilities | $237.28M |
| Long-term Debt | $222.90M |
| Other Non-current Liabilities | $14.39M |
| Equity | $636.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $636.37M |
| Liabilities And Equity | $937.61M |
| Net Cash Flow From Operating Activities | -$264.44M |
| Net Cash Flow From Operating Activities, Continuing | -$264.44M |
| Net Cash Flow From Investing Activities | -$399.53M |
| Net Cash Flow From Investing Activities, Continuing | -$399.53M |
| Net Cash Flow From Financing Activities | $878.23M |
| Net Cash Flow From Financing Activities, Continuing | $878.23M |
| Net Cash Flow | $214.26M |
| Net Cash Flow, Continuing | $214.26M |
| Comprehensive Income/Loss | -$329.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$329.03M |
| Other Comprehensive Income/Loss | -$92.00K |